Neurosteroids and cognitive functions in depressed women

Klinik Psikofarmakoloji Bulteni

Volumn 18, Issue 1, 2008, Pages 9-21

  Kartalci, Şükrü ^a   Eşel, Ertuǧrul ^b   Özsoy, Saliha ^b   Kula, Mustafa ^b   Turan, Tayfun ^b  

^a Psikiyatri Uzmani ^*

^b ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Cognitive functions; Dehydroepiandrosterone sulfate (DHEAS); Dexamethasone suppression test (DST); Hypothalamicpituitary adrenal (HPA) axis; Major depression; Neurosteroids

Indexed keywords

ANTIDEPRESSANT AGENT; DEXAMETHASONE; HYDROCORTISONE; NEUROSTEROID; PRASTERONE;

ADULT; AGED; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; LEARNING DISORDER; MEMORY DISORDER; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; TREATMENT RESPONSE;

EID: 41949096596     PISSN: 10177833     EISSN: 13029657     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. Strous RD, Maayan R, Weizman A. The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside. Eur Neuropsychopharmacol 2006; 16: 155-169
2. van Broekhoven F, Verkes RJ. Neurosteroids in depression: a review. Psychopharmacology (Berl) 2003; 165: 97-110
3. Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, Roberts E. Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 1999;156:646-649
4. Baulieu EE, Robel P. Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids. J Endocrinol 1996; 150 Suppl: S221-239
5. Wolf OT, Kirschbaum C. Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans. Brain Res Rev 1999; 30: 264-288
6. Kartalci Ş, Eşel E. Nörosteroidler: psikofarmakolojik ve davranişsal etkileri. Klinik Psikofarmakoloji Bülteni 2004; 14: 38-49
7. Herbert J. Neurosteroids, brain damage, and mental illness. Exp Gerontol 1998; 33: 713-727
8. Carroll BJ. Use of the dexamethasone suppression test in depression. J Clin Psychiatry. 1982; 43: 44-50
9. Rush JA, Giles DE, Schlesser MA, Orsulak PJ. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency and subtypes of depression. Biol Psychiatry 1997; 41: 915-928
10. Ozsoy S, Esel E. Hypothalamic-pituitary-adrenal axis activity, dehydroepiandrosterone sulphate and their relationships with aggression in early and late alcohol withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 2007 (in press)
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fourth ed. (DSM-IV) Washington, DC: American Psychiatric Press, 1994
12. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-61
13. Snaith RP, Baugh SJ, Clayden AD, Husain A, Sipple MA. The Clinical Anxiety Scale: an instrument derived from the Hamilton Anxiety Scale. Br J Psychiatry 1982; 141: 518-523
14. Öktem Ö. Sözel Bellek Süreçleri Testi (SBST). Bir önçalişma. Nöropskiatri Arşivi 1992; 29: 196-206
15. Öktem Ö. Hidrosefalide bellek bozukluǧu. Bozulma başlica hangi süreçleri tutar. Nöropskiatri Arşivi 1993; 30: 281-296
16. Demir B, Göǧüş A, Savaşir I. Depresyon hastalarinda bilişsel işlevler. Türk Psikiyatri Dergisi 2000; 11: 179-189
17. Wechsler D. Wechsler Memory Scale-Revised. The Psychological Corporation, San Antonio TX, 1987
18. Spreen O, Strauss E. A Compendimum of neuropsychological tests-administration, norm and commentary. Oxford University Press, New York 1991.
19. Karakaş S, Erdoǧan E, Sak L. Stroop Testi TBAG formu: Türk kültürüne standardizasyon çalişmalari, güvenirlik ve geçerlik. Klinik Psikiyatri Dergisi 1999;2:75-88
20. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James NM, Kronfol Z, Lohr N, Steiner M, de Vigne JP, Young E. A specific laboratory test for melancholia. Standardization, validation and clinical utility. Arch Gen Psychiatry 1981; 38: 15-22
21. Eşel E. Depresyondaki nöroendokrinolojik bulgular. Klinik Psikiyatri Dergisi 2002; 4: 35-50
22. Hatzinger M. Neuropeptides and the hypothalamic-pituitary-adrenocortical (HPA) system: review of recent research strategies in depression. World J Biol Psychiatry 2000; 1: 105-111
23. Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Ormiston S, Johnson R, Canick J, Brizendine L, Weingartner H. Antidepressant and cognition-enhancing effects of DHEA in major depression. Ann NY Acad Sci 1995; 774: 337-339
24. Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Raum WJ, Ormiston S, Johnson R, Canick J, Brizendine L, Weingartner H. Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry 1997; 41: 311-318
25. Goodyer M, Herbert J, Altham PM, Pearson J, Secher SM, Shiers HM. Adrenal secretion during major depression in 8 to 16 year olds, I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation. Psychol Med 1996; 26: 245-256
26. Barrett-Connor E, von Muhlen D, Laughlin GA, Kripke A. Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo study. J Am Geriatr Soc 1999; 47: 685-691
27. Osran H, Reist C, Chen CC, Lifrak ET, Chicz-DeMet A, Parker LN. Adrenal androgens and cortisol in major depression. Am J Psychiatry 1993; 150: 806-809
28. Fabian TJ, Dew MA, Pollock BG, Reynolds CF 3rd, Mulsant BH, Butters MA, Zmuda MD, Linares AM, Trottini M, Kroboth PD. Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults. Biol Psychiatry 2001; 50: 767-774
29. Maayan R, Yagorowski Y, Grupper D, Weiss M, Shtaif B, Kaoud MA, Weizman A. Basal plasma dehydroepian-drosterone sulfate level: a possible predictor for response to electroconvulsive therapy in depressed psychotic inpatients. Biol Psychiatry 2000; 48: 693-701
30. Weber B, Lewicka S, Deuschle M, Colla M, Heuser I. Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression. Psychoneuroendocrinology 2000; 25: 765-771
31. Hansen CR, Kroll F, MacKenzie TB. Dehydroepiandrosterone and affective disorders. Am J Psychiatry 1982;139:386-387
32. Tollefson GD, Haus E, Garvey MJ, Evans M, Tuason VB. 24 hour urinary dehydroepiandrosterone sulfate in unipolar depression treated with cognitive and/or pharmacotherapy. Ann Clin Psychiatry 1990; 2: 39-45
33. Takebayashi M, Kagaya A, Uchitomi Y, Kugaya A, Muraoka M, Yokota N, Horiguchi J, Yamawaki S. Plasma dehydroepiandrosterone sulfate in unipolar major depression. Short communication. J Neural Transm 1998; 105: 537-542
34. Heuser I, Deuschle M, Luppa P, Schweiger U, Standhardt H, Weber B. Increased diurnal plasma concentratitions of dehydroepiandrosterone in depressed patients. J Clin Endocrinol Metab 1998; 83: 3130-3132
35. Ferrari F, Cravello L, Muzzoni B. Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates. Eur J Endocrinol 2001; 144: 319-329
36. Legrain S, Berr C, Frenoy N, Gourlet V, Debuire B, Baulieu EE. Dehydroepiandrosterone sulfate in a long-term care aged population. Gerontology 1995; 41: 343-351
37. Romeo E, Ströhle A, Spalletta G, di Michele F, Hermann B, Holsboer F, Pasini A, Rupprecht R. Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 1998; 155: 910-913
38. Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA 1998; 95: 3239-3244
39. Ströhle A, Romeo E, Hermann B, Pasini A, Spalletta G, di Michele F, Holsboer F, Rupprecht R. Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol Psychiatry 1999; 45: 274-277
40. Do-Rego JL, Mensah-Nyagan GA, Beaujean D, Vaudry D, Sieghart W, Luu-The V, Pelletier G, Vaudry H. Gamma-aminobutyric acid, acting through gamma-aminobutyric acid type A receptors, inhibits the biosynthesis of neurosteroids in the frog hypothalamus. Proc Natl Acad Sci U S A 2000; 97: 13925-13930
41. Rosenfeld RS, Hellman L, Roffwarg H, Weitzman ED, Fukushima DK, Gallagher TF. Dehydroepiandrosterone is secreted episodically and synchronously with cortisol by normal man. J Clin Endocrinol 1971; 33: 87-92
42. Parker LN, Odell WD. Control of adrenal androgen secretion. Endocr Rev 1980; 1: 392-410
43. Hauffa BP, Kaplan SL, Grumbach MM. Dissociation between plasma adrenal androgens and cortisol in Cushing's disease and ectopic ACTH-producing tumor: relation to adrenarche. Lancet 1984; 1: 1373-1375
44. Eşel E, Kartalci Ş, Tutuş A, Turan T, Sofuoǧlu S. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 303-309
45. van Praag HM. Can stress cause depression. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 891-907
46. Calfa G, Kademian S, Ceschin D, Vega G, Rabinovich GA, Volosin M. Characterization and functional significance of glucocorticoid receptors in patients with major depression: modulation by antidepressant treatment. Psychoneuroendocrinology 2003; 28: 687-701
47. Holsboer F, Von Bardeleben U, Gerken A, Stalla GK, Muller OA. Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N Engl J Med 1984; 311: 1127
48. Michael A, Jenaway A, Paykel ES, Herbert J. Altered salivary dehydroepiandrosterone levels in major depression in adults. Biol Psychiatry 2000; 48: 989-995
49. Dazzi L, Vignone V, Seu E, Ladu S, Vacca G, Biggio G. Inhibition by venlafaxine of the increase in norepinephrine output in rat prefrontal cortex elicited by acute stress or by the anxiogenic drug FG 7142. J Psychopharmacol 2002; 16: 125-131
50. Pisu MG, Serra M. Neurosteroids and neuroactive drugs in mental disorders. Life Sci 2004; 74: 3181-3197
51. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000; 3: 477-501
52. Czlonkowska AI, Zienowicz M, Bidzinski A, Maciejak P, Lehner M, Taracha E, Wislowska A, Plaznik A. The role of neurosteroids in the anxiolytic, antidepressive and anticonvulsive effects of selective serotonin reuptake inhibitors. Med Sci Monit 2003; 9: 270-275
53. Li Q, Levy AD, Cabrera TM, Brownfield MS, Battaglia G, Van de Kar LD. Long-term fluoxetine, but not desimipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH -DPAT, in male rats. Brain Res 1993; 630:148-156
54. Raap DK, Garcia F, Muma NA, Wolf WA, Battaglia G, van de Kar LD. Sustained desensitization of hypothalamic 5-Hydroxytryptamine1A receptors after discontinuation of fluoxetine: inhibited neuroendocrine responses to 8-hydroxy-2 (Dipropylamino) Tetralin in the absence of changes in Gi/o/z proteins. J Pharmacol Exp Ther 1999; 288: 561-567
55. Jorgensen H, Knigge U, Kjaer A, Warberg J. Adrenocorticotropic hormone secretion in rats induced by stimulation with serotonergic compounds. J Neuroendocrinol 1999; 11: 283-290
56. Khisti RT, Chopde CT, Jain SP. Antidepressant like effect of the neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one in mice forced swim test. Pharmacol Biochem Behav 2000; 67: 137-143
57. Khisti RT, Chopde CT. Serotonergic agents modulate antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice. Brain Res 2000; 865: 291-300
58. Patchev VK, Shoaib M, Holsboer F, Almeida OF. The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience 1994; 62: 265-271
59. Patchev VK, Hassan AH, Holsboer DF, Almeida OF. The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 1996; 15: 533-540
60. Austin MP, Mitchell P, Goodwin GM. Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry 2001; 178: 200-206
61. Sternberg DE, Jarvik ME. Memory functions in depression. Arch Gen Psychiatry 1976; 33: 219-224
62. Calev A, Korin Y, Shapira B, Kugelmass S, Lerer B. Verbal and non-verbal recall by depressed and euthymic affective patients. Psychol Med 1986; 16: 789-794
63. Peselow ED, Corwin J, Fieve RR, Rotrosen J, Cooper TB. Disappearance of memory deficits in outpatient depressives responding to imipramine. J Affect Disord 1991; 21: 173-183
64. Bazin N, Perruchet P, De Bonis M, Feline A. The dissociation of explicit and implicit memory in depressed patients. Psychol Med 1994; 24: 239-245
65. Beats BC, Sahakian BJ, Levy R. Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychol Med 1996; 26: 591-603
66. Marcos T, Salamero M, Gutierrez F, Catalan R, Gasto C, Lazaro L. Cognitive dysfunction in recovered melancholic patients. J Affect Disord 1994; 32: 133-137
67. Paradiso S, Lamberty GJ, Garvey MJ, Robinson RG. Cognitive impairment in the euthymic phase of chronic unipolar depression. J Nerv Ment Dis 1997; 185: 748-754
68. Belanoff KJ, Gross K, Yager A, Schatzberg AF. Corticosteroids and cognition. J Psychiat Res 2001; 35: 127-145
69. Lupien SJ, McEwen BS. The acute effects of corticosteroids on cognition: integration of animal and human model studies. Brain Res 1997; 24: 1-27
70. Demirci S, Eşel E. Öǧrenme ve hafizanin hücresel düzenekleri ve psikiyatrik hastaliklarla ilişkisi. Anadolu Psikiyatri Dergisi 2004; 5: 239-248
71. Moghaddam B. Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders. Biol Psychiatry 2002; 51: 775-787
72. Erickson K, Drevets W, Schulkin J. Glucocorticoid regulation of diverse cognitive functions in normal and pathological emotional states. Neurosci Biobehav Rev 2003; 27: 233-246
73. Berr C, Lafont S, Debuire B, Dartigues JF, Baulieu EE. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc Natl Acad Sci U S A 1996; 93: 13410-13415
74. Yaffe K, Ettinger B, Pressman A, Seeley D, Whooley M, Schaefer C, Cummings S. Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study. Biol Psychiatry 1998; 43: 694-700
75. Carlson LE, Sherwin BB. Relationships among cortisol, dehydroepiandrosterone-sulfate and memory in a longitudinal study of healthy elderly men and women. Neurobiol Aging 1999; 20: 315-324
76. Bloch M, Schmidt PJ, Danaceau MA, Adams LF, Rubinow DR. Dehydroepiandrosterone treatment of midlife dysthymia. Biol Psychiatry 1999; 45: 1533-1541
77. Majewska MD. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurobiol 1992; 28: 379-395
78. Introini-Collison IB, Castellano C, McGaugh JL. Interaction of GABAergic and beta-noradrenergic drugs in the regulation of memory storage. Behav Neural Biol 1994; 61: 150-155